lizkat
Watching March roll out real winter
- Joined
- Aug 15, 2020
- Posts
- 7,341
Need to fix that poll and add the winning answer: the godblasted pharmaceutical industry is what American voters may well remember most. Not that they so far seem able to shake off K-street's hold no matter which way they vote.
Big pharma gives campaign donations to both sides of the aisle, and also runs plenty money into no-disclosure PACs and so supports ads running under innocuous-sounding names like "A Healthy Future" or "A Public Voice"... and the industry doesn't give a damn about "American voters" except the votes of members of the House or Senate, so long held in thrall. As the piece cited below points out, there are three times more registered pharma lobbyists than there are members of Congress.
Big pharma gives campaign donations to both sides of the aisle, and also runs plenty money into no-disclosure PACs and so supports ads running under innocuous-sounding names like "A Healthy Future" or "A Public Voice"... and the industry doesn't give a damn about "American voters" except the votes of members of the House or Senate, so long held in thrall. As the piece cited below points out, there are three times more registered pharma lobbyists than there are members of Congress.
Other industries, including tobacco and electric vehicles, have worked aggressively to pare down or reshape parts of the bill in their favor, too. But the effort to fight back on drug-price increases stands out because of the enormous scope of the campaign waged by the pharmaceutical industry and its allies, which have derailed similar proposals for the past two decades, despite how popular many of the changes are with voters, according to polling data.
“They’re the Goliath,” said Sheila Krumholz, executive director of OpenSecrets. She said that aside from the U.S. Chamber of Commerce, of which pharmaceutical firms are members, the industry had spent more than any other by a wide margin so far this year, deploying so many lobbyists — 1,600 — that they outnumber members of Congress 3 to 1.
The industry made $90.6 million of political contributions during the 2020 election cycle, according to OpenSecrets, 61 percent of that to Democratic candidates and groups.
The industry’s focus on drug pricing has increased dramatically in recent years as the issue became more top-of-mind for voters. In 2012, lobbyists registered to work on the issue of “drug prices” 69 times for 20 different clients. In 2021 so far, they have filed to lobby on the issue 1,192 times for 242 different clients, according to OpenSecrets data.